- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x R16: HEXADECANE(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.7: 7 residues within 4Å:- Chain A: T.496, L.497, A.500, M.501, H.503, N.1350, L.1352
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:T.496, A:L.497, A:A.500, A:M.501
- Hydrogen bonds: A:H.503
- Salt bridges: A:H.503
Y01.15: 9 residues within 4Å:- Chain A: N.299, I.300, L.301, V.1486, M.1489, M.1490, F.1492
- Ligands: R16.13, R16.16
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.300, A:L.301, A:L.301, A:V.1486, A:F.1492
Y01.24: 7 residues within 4Å:- Chain A: I.1165, A.1168, A.1169, R.1179, F.1611, F.1641, L.1642
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:I.1165, A:I.1165, A:A.1168, A:A.1169, A:F.1611, A:F.1641, A:F.1641, A:L.1642, A:L.1642, A:L.1642
- Salt bridges: A:R.1179, A:R.1179
- 1 x PT5: [(2R)-1-octadecanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phospho ryl]oxy-propan-2-yl] (8Z)-icosa-5,8,11,14-tetraenoate(Non-covalent)
PT5.25: 21 residues within 4Å:- Chain A: K.480, K.532, S.544, S.545, F.546, N.547, L.583, R.584, K.587, W.592, L.595, R.596, L.598, V.599, L.602, I.609, F.1292, V.1401, V.1402, F.1406, F.1407
22 PLIP interactions:22 interactions with chain A- Hydrophobic interactions: A:L.583, A:L.595, A:L.598, A:V.599, A:I.609, A:F.1292, A:F.1292, A:V.1402, A:F.1406, A:F.1406, A:F.1406, A:F.1406, A:F.1407
- Hydrogen bonds: A:S.544, A:S.545, A:F.546, A:N.547
- Salt bridges: A:K.480, A:K.532, A:R.584, A:K.587, A:K.587
- 2 x CA: CALCIUM ION(Non-covalent)
CA.26: 4 residues within 4Å:- Chain A: D.122
- Chain D: S.261, S.263, T.331
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain D- Metal complexes: A:D.122, D:S.263, D:T.331
CA.27: 4 residues within 4Å:- Chain A: E.314, E.663, E.1365, E.1655
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:E.314, A:E.314, A:E.663, A:E.1365
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.28: 3 residues within 4Å:- Chain D: L.89, N.92, E.199
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:L.89
- Hydrogen bonds: D:N.92, D:E.199
NAG.29: 1 residues within 4Å:- Chain D: N.324
No protein-ligand interaction detected (PLIP)NAG.30: 2 residues within 4Å:- Chain D: N.346, N.348
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:N.346
NAG.31: 4 residues within 4Å:- Chain D: T.587, F.588, R.589, N.604
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:T.587
NAG.32: 4 residues within 4Å:- Chain D: E.80, A.83, R.84, N.613
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:A.83, D:R.84
- Hydrogen bonds: D:E.80, D:R.84, D:N.613
NAG.33: 4 residues within 4Å:- Chain D: N.675, T.677, E.678, L.681
No protein-ligand interaction detected (PLIP)NAG.34: 1 residues within 4Å:- Chain D: N.888
No protein-ligand interaction detected (PLIP)NAG.35: 6 residues within 4Å:- Chain D: V.107, R.114, N.120, N.184, W.185, S.187
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:V.107
- Hydrogen bonds: D:R.114, D:N.120, D:S.187
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dong, Y. et al., Closed-state inactivation and pore-blocker modulation mechanisms of human Ca V 2.2. Cell Rep (2021)
- Release Date
- 2021-11-03
- Peptides
- Voltage-dependent N-type calcium channel subunit alpha-1B: A
Omega-conotoxin MVIIA: B
Voltage-dependent L-type calcium channel subunit beta-1: C
Voltage-dependent calcium channel subunit alpha-2/delta-1: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
EC
DD
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x R16: HEXADECANE(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 1 x PT5: [(2R)-1-octadecanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phospho ryl]oxy-propan-2-yl] (8Z)-icosa-5,8,11,14-tetraenoate(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dong, Y. et al., Closed-state inactivation and pore-blocker modulation mechanisms of human Ca V 2.2. Cell Rep (2021)
- Release Date
- 2021-11-03
- Peptides
- Voltage-dependent N-type calcium channel subunit alpha-1B: A
Omega-conotoxin MVIIA: B
Voltage-dependent L-type calcium channel subunit beta-1: C
Voltage-dependent calcium channel subunit alpha-2/delta-1: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
EC
DD
B - Membrane
-
We predict this structure to be a membrane protein.